ThesisGemcitabine as monotherapy for locally advanced and/or metastatic carcinoma of bilharzial bladder in comparison with epirubicin
ThesisGemcitabine as monotherapy for locally advanced and/or metastatic carcinoma of bilharzial bladder in comparison with epirubicin
ThesisEffect of protracted radiotherapy treatment on outcome of head and neck cancer patients : NEMROCK Experience
ThesisEffect of protracted radiotherapy treatment on outcome of head and neck cancer patients : NEMROCK Experience
ThesisProspective study of efficacy of cisplatin and vinorelbine in p 53 positive and negative advanced non-small cell lung cancer
ThesisProspective study of efficacy of cisplatin and vinorelbine in p 53 positive and negative advanced non-small cell lung cancer
ThesisStudy of induction paclitaxel and cisplatin followed by standard radiotherapy vs hyper fractionated radiotherapy and cisplatin as radio sensitizer for patients with unresectable stage IIIA and IIIB non-small cell lung cancer
ThesisStudy of induction paclitaxel and cisplatin followed by standard radiotherapy vs hyper fractionated radiotherapy and cisplatin as radio sensitizer for patients with unresectable stage IIIA and IIIB non-small cell lung cancer
ThesisProspective comparative study between concurrent temozolamide with radiation therapy versus concurrent treatment followed by adjuvant temozolamide in glioblastoma multiforme
ThesisProspective comparative study between concurrent temozolamide with radiation therapy versus concurrent treatment followed by adjuvant temozolamide in glioblastoma multiforme
ThesisComparative prospective study of temozolomide as a radiosensitizer by different protocols in glioblastoma multiform
ThesisComparative prospective study of temozolomide as a radiosensitizer by different protocols in glioblastoma multiform
ThesisA comparative study between conformal and intensity modulated radiation therapy in the treatment of primary nasopharyngeal carcinomas
ThesisA comparative study between conformal and intensity modulated radiation therapy in the treatment of primary nasopharyngeal carcinomas